Basic Information
AbilityPharma is a clinical-stage biopharmaceutical company focused on developing first-in-class, fully differentiated oral targeted anticancer compounds that selectively induce autophagy-mediated cytotoxicity in cancer cells. The company is committed to shaping the future of oncology by developing innovative therapies that induce autophagy to address unmet medical needs.
Ability Pharmaceuticals, SL
Barcelona,Catalonia,Spain
less than 15 people
January 01, 2009
contact@abilitypharma.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios